Daily Anesthesiology Research Analysis
Analyzed 91 papers and selected 3 impactful papers.
Summary
Today's most impactful research spans translational precision medicine, mechanistic thrombosis biology, and emergency cardiovascular care. Particularly notable are the validation of inflammatory phenotypes across human pneumonia and mouse models, the discovery that cold-induced adipose thermogenesis promotes venous occlusion through platelet production, and a nationwide Japanese analysis demonstrating the time-sensitive benefit of public-access defibrillation.
Research Themes
- Phenotype-guided precision therapeutics in severe pneumonia
- Cold-induced platelet production and venous thrombosis
- Time-dependent effectiveness of public-access defibrillation
Selected Articles
1. Cold exposure aggravates vein occlusion through non-shivering thermogenesis-induced thrombocytopoiesis.
This study demonstrates that cold exposure increases platelet production through adipose thermogenesis and circulating free fatty acids. The mechanistic pathway involves fatty-acid β-oxidation, acetyl-CoA, p300/SIRT1-dependent regulation of C/EBPα, and downstream GATA-1/NF-E2 activation in megakaryocytes. Genetic or pharmacological interruption of this pathway reduced deep venous thrombosis and retinal vein occlusion in mice, while human observations showed increased platelet counts during cold exposure and cold seasons.
Impact: The paper provides a previously unrecognized mechanistic explanation for the seasonal increase in venous occlusive disease and identifies megakaryocyte metabolism as a potentially targetable pathway. It is strengthened by concordant evidence from mouse models, genetic manipulation, pharmacological inhibition, healthy volunteers, and patient cohorts.
Clinical Implications: Cold exposure may represent a modifiable environmental risk factor for venous thrombotic disease, particularly in susceptible individuals. The identified fatty-acid oxidation and p300-related pathways may support future preventive or therapeutic strategies, but no clinical treatment recommendation can yet be made.
Key Findings
- Cold exposure increased platelet counts and aggravated deep venous thrombosis and retinal vein occlusion in mouse models.
- Adipose thermogenesis increased circulating free fatty acids, whose β-oxidation promoted acetyl-CoA-dependent C/EBPα stabilization and megakaryocyte platelet production.
- Inhibition of adipose triglyceride lipase, megakaryocyte CPT1α, or p300 reduced cold-induced thrombocytopoiesis and venous occlusion.
- Cold exposure increased platelet counts in healthy volunteers, and cold-season platelet elevation and higher deep venous thrombosis incidence were observed in patient cohorts.
Methodological Strengths
- Mechanistic validation across animal models, genetic perturbation, pharmacological inhibition, healthy volunteers, and clinical cohorts.
- The pathway was tested at multiple biological levels from adipose thermogenesis and lipid metabolism to megakaryocyte maturation and thrombosis.
Limitations
- The human component is observational and cannot establish that cold-induced platelet elevation causes venous occlusion in humans.
- The therapeutic effects of pathway inhibition were demonstrated in mice and require safety and efficacy testing in humans.
Future Directions: Future studies should prospectively determine whether seasonal cold exposure modifies thrombotic risk in defined high-risk populations and evaluate selective inhibition of megakaryocyte fatty-acid oxidation or p300 without impairing normal hemostasis.
Vein occlusion (VO), including deep venous thrombosis (DVT) and retinal vein occlusion (RVO), is a common cause of multiple diseases that severely compromise the quality of life of affected individuals. Epidemiological evidence indicates that VO prevalence increases in cold seasons, yet the underlying mechanism remains unknown. Here, we show that cold exposure markedly elevates peripheral platelet counts, thereby aggravating VO in mouse models. Cold-augmented thrombocytopoiesis depends on the activation of adipose thermogenesis and subsequent increase in circulating free fatty acid (FFA) levels. Mechanistically, FFA-β-oxidation promotes acetyl-CoA production, which upregulates and stabilizes C/EBPα by shifting the balance between p300 acetyltransferase and SIRT1 deacetylase. Acetyl-C/EBPα transcriptionally upregulates GATA-1 and NF-E2 for megakaryocyte maturation and platelet production.
2. Inflammatory Phenotypes In Severe Pneumonia: Clinical Evidence To Mouse Models For Precision Therapeutics.
Latent class analysis identified hyperinflammatory and hypoinflammatory phenotypes among 548 critically ill patients with pulmonary sepsis; the hyperinflammatory phenotype was associated with greater lung injury and mortality. A pneumococcal pneumonia mouse model reproduced divergent inflammatory trajectories despite uniform pathogen exposure, and dexamethasone or IL-6 receptor blockade benefited only the more inflamed phenotype. This provides a clinically anchored framework for phenotype-targeted therapy in severe pneumonia.
Impact: This study links clinically defined inflammatory subgroups to experimentally reproducible phenotypes and differential treatment responses, addressing a major barrier in translating sepsis and acute respiratory distress syndrome biology into precision therapeutics. Its human-to-mouse design supports mechanistic inference while preserving clinical relevance.
Clinical Implications: Routine biomarker-based phenotyping may eventually identify pneumonia patients more likely to benefit from immunomodulatory therapy. The findings support prospective trials that stratify patients by inflammatory phenotype rather than applying uniform anti-inflammatory treatment.
Key Findings
- Among 548 patients with pulmonary sepsis, two inflammatory phenotypes were identified; the hyperinflammatory phenotype had greater lung injury and mortality.
- A pneumococcal pneumonia mouse model reproduced distinct inflammatory trajectories despite uniform pathogen exposure and baseline conditions.
- Dexamethasone and interleukin-6 receptor blockade produced therapeutic benefit exclusively in the more inflamed mouse phenotype.
Methodological Strengths
- Integration of latent class analysis in a 548-patient clinical cohort with a mechanistically characterized bacterial pneumonia model.
- Testing of phenotype-specific responses to two clinically relevant anti-inflammatory interventions.
Limitations
- The clinical phenotype classification is observational and does not establish that the identified subgroups are caused by a single biological mechanism.
- The mouse model cannot reproduce the full heterogeneity, comorbidity burden, and treatment context of human severe pneumonia.
Future Directions: Prospective biomarker-stratified clinical trials should test whether phenotype-guided corticosteroid or interleukin-6 pathway therapy improves outcomes and should evaluate the stability of phenotypes over time.
RATIONALE: Hyperinflammatory and hypoinflammatory phenotypes previously identified in sepsis and ARDS may enable precision therapies, but their clinical relevance and translational modeling in severe pneumonia remain incompletely characterized. OBJECTIVES: To examine biomarker-defined hyperinflammatory and hypoinflammatory phenotypes in critically ill patients with pneumonia (pulmonary sepsis), test whether the biomarkers that define these phenotypes identify subgroups and outcomes in a mouse model of bacterial pneumonia, and determine whether the mouse phenotypes respond differently to therapeutic interventions. METHODS: We performed latent class analysis (LCA) in a cohort of 548 ICU patients with pulmonary sepsis to identify inflammatory phenotypes and test the association of these phenotypes with clinical outcomes using validated classifier models. We developed a mouse model of pneumococcal pneumonia which recapitulates key aspects of these phenotypes and tested responses to dexamethasone and IL-6 receptor blockade.
3. Timing of Public-Access Defibrillation for Patients With Out-of-Hospital Cardiac Arrest: A Nationwide Cohort Study Using Time-Dependent Propensity Score Sequential Matching Approach.
In a nationwide prospective Japanese registry, 1,664 matched pairs of bystander-witnessed ventricular fibrillation cardiac arrests in public locations were analyzed using minute-by-minute time-dependent propensity score matching. Public-access defibrillation before emergency medical services arrival was associated with a 46% higher relative probability of 1-month survival with favorable neurological outcome. The association remained directionally favorable across defibrillation timing categories, although estimates were imprecise after 15 minutes.
Impact: This study addresses resuscitation time bias, a major methodological problem in evaluating public-access defibrillation, by matching patients according to their minute-by-minute risk of receiving the intervention. Its nationwide population-based design provides strong evidence supporting rapid community defibrillation programs.
Clinical Implications: The findings support continued deployment of automated external defibrillators in public locations, improved public training, and systems that minimize the interval between collapse recognition and defibrillation. Emergency response policies should prioritize rapid bystander intervention before emergency medical services arrival.
Key Findings
- After time-dependent sequential matching, 1,664 matched pairs of bystander-witnessed ventricular fibrillation arrests were identified.
- Public-access defibrillation was associated with a corrected relative risk of 1.46 for 1-month survival with favorable neurological outcome.
- Effect estimates remained directionally favorable for defibrillation within 0–4, 5–9, and 10–14 minutes, with wider uncertainty after 15 minutes.
Methodological Strengths
- Use of a nationwide prospective population-based registry with a clinically meaningful neurological outcome.
- Minute-by-minute time-dependent propensity score sequential matching directly addresses resuscitation time bias.
Limitations
- The observational design cannot eliminate residual confounding, including differences in location, witness characteristics, and CPR quality.
- The analysis was restricted to bystander-witnessed ventricular fibrillation arrests in public locations, limiting generalizability to other arrest rhythms and settings.
Future Directions: Future research should evaluate integrated community response systems, including dispatcher-assisted CPR, smartphone-based responder activation, automated external defibrillator drones, and the effectiveness of public-access defibrillation in nonpublic settings and nonshockable rhythms.
BACKGROUND: Earlier defibrillation is a key factor in improving survival in patients with out-of-hospital cardiac arrest due to ventricular fibrillation. Although the benefit of public-access defibrillation (PAD) has been reported, its effectiveness has rarely been evaluated considering intervention time. We assessed whether the effect of PAD varies depending on the timing of defibrillation. METHODS: Using a nationwide, prospective, population-based out-of-hospital cardiac arrest registry in Japan between 2022 and 2023, we included consecutive bystander-witnessed ventricular fibrillation with resuscitation attempts in public locations. Patients with out-of-hospital cardiac arrest who received PAD before emergency medical services arrival were sequentially matched with patients at risk of receiving PAD on a minute-by-minute basis using time-dependent propensity scores to address resuscitation time bias. The primary outcome was 1-month survival with favorable neurological outcome, defined as a cerebral performance category scale of 1 or 2.